TIAA CREF Investment Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q1
$2.8M Hold
511,523
﹤0.01% 1811
2018
Q4
$1.55M Hold
511,523
﹤0.01% 2100
2018
Q3
$2.15M Hold
511,523
﹤0.01% 2088
2018
Q2
$1.98M Sell
511,523
-186,105
-27% -$719K ﹤0.01% 2179
2018
Q1
$4.42M Sell
697,628
-3,138
-0.4% -$19.9K ﹤0.01% 1630
2017
Q4
$5.65M Sell
700,766
-13,925
-2% -$112K ﹤0.01% 1534
2017
Q3
$8.18M Buy
714,691
+7,483
+1% +$85.6K 0.01% 1277
2017
Q2
$6.9M Sell
707,208
-104,340
-13% -$1.02M ﹤0.01% 1375
2017
Q1
$19.7M Sell
811,548
-2,349
-0.3% -$56.9K 0.01% 757
2016
Q4
$26.1M Buy
813,897
+75,855
+10% +$2.44M 0.02% 656
2016
Q3
$36.9K Buy
738,042
+32,248
+5% +$1.61K 0.02% 539
2016
Q2
$29.9M Buy
705,794
+11,129
+2% +$472K 0.02% 581
2016
Q1
$45.7M Buy
694,665
+47,918
+7% +$3.16M 0.04% 459
2015
Q4
$40.2M Buy
646,747
+66,586
+11% +$4.14M 0.03% 529
2015
Q3
$38.8M Buy
580,161
+185,729
+47% +$12.4M 0.03% 518
2015
Q2
$38.4M Buy
394,432
+66,843
+20% +$6.5M 0.03% 560
2015
Q1
$30.6M Buy
327,589
+272,076
+490% +$25.4M 0.02% 634
2014
Q4
$4.94M Sell
55,513
-2,811
-5% -$250K ﹤0.01% 1635
2014
Q3
$4.03M Sell
58,324
-1,556
-3% -$107K ﹤0.01% 1767
2014
Q2
$3.43M Buy
59,880
+1,153
+2% +$66.1K ﹤0.01% 1944
2014
Q1
$2.33M Buy
58,727
+2,227
+4% +$88.3K ﹤0.01% 2148
2013
Q4
$2.37M Sell
56,500
-1,766
-3% -$74.2K ﹤0.01% 2149
2013
Q3
$1.74M Buy
58,266
+11,399
+24% +$341K ﹤0.01% 2302
2013
Q2
$2.48M Buy
+46,867
New +$2.48M ﹤0.01% 2028